BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28206957)

  • 1. Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterparts.
    Wang J; Wang J; Li Q; Zhang P; Yuan P; Ma F; Luo Y; Cai R; Fan Y; Chen S; Li Q; Xu B
    Oncotarget; 2017 Jul; 8(27):44851-44859. PubMed ID: 28206957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.
    Ye J; Wang W; Xin L; Owen S; Xu L; Duan X; Cheng Y; Zhang H; Zhang S; Li T; Liu Y
    Anticancer Res; 2017 Aug; 37(8):4549-4556. PubMed ID: 28739751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy.
    Ho AY; Gupta G; King TA; Perez CA; Patil SM; Rogers KH; Wen YH; Brogi E; Morrow M; Hudis CA; Traina T; McCormick B; Powell SN; Robson ME
    Cancer; 2012 Oct; 118(20):4944-52. PubMed ID: 22392492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
    J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes.
    Kim SW; Chun M; Han S; Jung YS; Choi JH; Kang SY; Yim H; Kang SH
    Cancer Res Treat; 2017 Apr; 49(2):484-493. PubMed ID: 27554479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
    Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
    Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
    Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
    Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.
    Haffty BG; Reiss M; Beinfield M; Fischer D; Ward B; McKhann C
    J Clin Oncol; 1996 Jan; 14(1):52-7. PubMed ID: 8558220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment.
    Shenouda MN; Sadek BT; Goldberg SI; Keruakous AR; Croft BJ; Abi Raad RF; Taghian AG
    Clin Breast Cancer; 2014 Jun; 14(3):198-204. PubMed ID: 24485702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors on outcomes in metaplastic breast cancer.
    Leyrer CM; Berriochoa CA; Agrawal S; Donaldson A; Calhoun BC; Shah C; Stewart R; Moore HCF; Tendulkar RD
    Breast Cancer Res Treat; 2017 Oct; 165(3):499-504. PubMed ID: 28689362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
    van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
    Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying long-term survivors among metastatic breast cancer patients undergoing primary tumor surgery.
    Yoo TK; Chae BJ; Kim SJ; Lee J; Yoon TI; Lee SJ; Park HY; Park HK; Eom YH; Kim HS; Kim CJ; Shin MS; You SH; Song BJ
    Breast Cancer Res Treat; 2017 Aug; 165(1):109-118. PubMed ID: 28573447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments.
    Yu JI; Park W; Choi DH; Huh SJ; Nam SJ; Kim SW; Lee JE; Kil WH; Im YH; Ahn JS; Park YH; Cho EY
    Clin Breast Cancer; 2015 Dec; 15(6):512-8. PubMed ID: 26188791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
    Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
    Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.